Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Antibiotic Resistance
100%
Plasmid
95%
Acinetobacter Baumannii
94%
Infection
74%
Infectious Disease
74%
Helicobacter Pylori
62%
Escherichia coli
61%
Infectious Agent
44%
Minimum Inhibitory Concentration
43%
Gram-Negative Bacteria
42%
Campylobacter
41%
Bacterium
37%
Cladistics
34%
Antibiotic Sensitivity
32%
Pseudomonas aeruginosa
28%
Colistin
23%
Antimicrobial Resistance Genes
23%
Biofilm
22%
Multilocus Sequence Typing
22%
Bacteriophage
22%
Gene Insertion Sequence
21%
Antimicrobial Agent
21%
Campylobacter Jejuni
20%
Prevalence
20%
Whole Genome Sequencing
20%
Klebsiella pneumoniae
19%
Genetic Variability
18%
Antimicrobial Peptides
18%
Dilution
18%
Escherichia Coli O157:H7
17%
Pathogenicity Island
17%
Molecular Epidemiology
17%
Genetic Variation
17%
Klebsiella
16%
Type Strain
15%
Agar Dilution
14%
Acinetobacter
13%
Outer Membrane
13%
Microbiology
13%
Gene Expression
12%
Verotoxin-Producing Escherichia Coli
12%
Comparative Genomics
11%
Taxon
11%
Ribosomal RNA
11%
Stomach Mucosa
11%
Microorganism
11%
Genomic Epidemiology
11%
Resistant Strain
10%
Neutrophil
10%
Disk Diffusion
10%
Keyphrases
Acinetobacter Baumannii (A. baumannii)
52%
BlaOXA
40%
Carbapenem Resistance
32%
BlaOXA-58
26%
Carbapenem-resistant Acinetobacter Baumannii
21%
Escherichia Coli
21%
ISAba1
21%
Antimicrobial Resistance
19%
Escherichia Coli Pathotypes
17%
BlaOXA-23
16%
Plasmid-borne
15%
Carbapenem
14%
Plasmid
14%
Resistance Genes
13%
Clinically Significant
12%
Public Health
11%
Imipenem
11%
Pulsed-field Gel Electrophoresis
11%
Egypt
11%
Shenzhen, China
10%
Meropenem
10%
Gram-negative Bacteria
10%
India
10%
Acinetobacter
10%
Minimum Inhibitory Concentration
9%
Baumannii
9%
Helicobacter Pylori (H. pylori)
8%
Multidrug-resistant
8%
Genome Analysis
8%
Carbapenemases
8%
Campylobacter
8%
Nigeria
8%
Defense System
8%
Immunocompromised Pediatric Patients
8%
Fetus
8%
Genomic Insights
8%
Dynamic Molecular Docking
8%
Genus Bacillus
8%
Chile
8%
HIV-positive Mothers
8%
Antimicrobial Susceptibility Profile
8%
R. Equi
8%
Bovine Host
8%
South Asia
8%
Effective Tool
8%
Cephalosporins
8%
Frameshift
8%
Major Challenges
8%
World Population
8%
Shiga Toxin-producing Escherichia Coli O157:H7
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter Baumannii
53%
Antibiotic Resistance
48%
Infectious Agent
36%
Antiinfective Agent
27%
Antimicrobial Agent
25%
Escherichia coli
19%
Penicillinase
17%
Helicobacter Pylori
17%
Antioxidant
17%
Antibiotics
16%
Meropenem
14%
Imipenem
14%
Ceftazidime
14%
Infection
12%
Enzymes
12%
Ciprofloxacin
11%
Beta Lactamase
11%
Bacterium
10%
Carbapenem Derivative
8%
Effusion
8%
Anti-Inflammatory Drug
8%
Atenolol
8%
Copper Nanoparticle
8%
Tinospora cordifolia
8%
Peptide
8%
Liquorice
8%
Streptococcus mutans
8%
Resveratrol
8%
Copper Oxide Nanoparticle
8%
Campylobacter
8%
Adrenergic Receptor
8%
Symbiont
8%
Amoxicillin
8%
Minimum Inhibitory Concentration
6%
Carbapenem
6%
Morbidity
5%